Simplex Trading, LLC Ligand Pharmaceuticals Inc Transaction History

Simplex Trading, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$69.53 - $79.33 $13,002 - $14,834	187 New	187 $13,000
Q4 2022 Feb 02, 2023	SELL	$61.72 - $96.74 $802 - $1,257	-13 Reduced 3.41%	368 $24,000
Q3 2022 Nov 04, 2022	SELL	$0.01 - $107.56 $70 - $763,245	-7,096 Reduced 94.9%	381 $32,000
Q2 2022 Aug 03, 2022	BUY	$74.52 - $117.06 $546,380 - $858,283	7,332 Added 5056.55%	7,477 $667,000
Q1 2022 May 02, 2022	BUY	$94.99 - $151.56 $13,773 - $21,976	145 New	145 $16,000
Q1 2020 Apr 29, 2020	SELL	$63.37 - $107.88 $134,851 - $229,568	-2,128 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$96.94 - $113.59 $130,287 - $152,664	1,344 Added 171.43%	2,128 $221,000
Q3 2019 Oct 15, 2019	BUY	$86.25 - $120.16 $67,620 - $94,205	784 New	784 $78,000
Q4 2018 Jan 16, 2019	SELL	$128.36 - $272.13 $312,941 - $663,452	-2,438 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$211.18 - $274.49 $96,720 - $125,716	458 Added 23.13%	2,438 $669,000
Q2 2018 Jul 30, 2018	BUY	$150.77 - $207.98 $298,524 - $411,800	1,980 New	1,980 $410,000
Q1 2018 Apr 26, 2018	SELL	$138.63 - $182.62 $278,230 - $366,518	-2,007 Closed	0 $0
Q4 2017 Jan 10, 2018	BUY	$128.36 - $147.04 $53,526 - $61,315	417 Added 26.23%	2,007 $274,000
Q3 2017 Oct 25, 2017	BUY	$120.91 - $137.94 $192,246 - $219,324	1,590	1,590 $216,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.